Using imaging and blood tests to find lung cancer earlier
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a new way to help find lung cancer earlier by combining imaging (like CT scans) with a blood test that looks at DNA changes. If you have lung cancer and haven't started treatment yet, participating may help improve future detection methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 74 years old.
- You have been diagnosed with cancer (confirmed by tests or a doctor's exam).
- You have not yet received any cancer treatment like surgery, chemo, or radiation.
- You have no history of other cancers (besides the current one).
- You have not had antibiotics, steroids, or certain other medications in the last 14 days, and no blood transfusion in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This trial tests whether a simple blood test (ctDNA) can help doctors decide if you need radiation therapy after lung cancer surgery. The goal is to tailor your treatment to your individual risk, possibly avoiding extra radiation if you don't need it.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.